Details of issuance or disposal
Total amount paid in: ¥942 million; estimated net proceeds: Not disclosed
| Item | Details |
|---|---|
| Amount of funds to be raised | Total amount paid in: ¥942 million; estimated net proceeds: Not disclosed |
| Specific use of funds | Details M&A funds (acquisition of shares from minority shareholders of a consolidated subsidiary) / Amount ¥26 million (already allocated) / Scheduled timing of expenditures January and April 2026, Details Funds for the acquisition of shares related to taking the Company private and associated expenses, including funds required to acquire the Company's shares through a tender offer for treasury shares / Amount ¥916 million / Scheduled timing of expenditures November 2026 to April 2027 |
| Number of Stock Acquisition Rights | Total issued: Not disclosed; unexercised balance: 9,300 units (all acquired and cancelled on 15 July 2025) |
| Most recent equity financing | Timing Announced 25 September 2023 / Type Issuance and exercise of the Fourth Stock Acquisition Rights issued through a third-party allotment / Amount Cumulative total: ¥942 million |
| Impact on Business Performance | There is no impact from this change in the use of funds. |
Items this document does not state (23)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.As of today, there are no specific M&A transactions scheduled for execution, while a series of transactions to take the Company private is under way. Accordingly, it was determined that changing the use of the unallocated funds to funds for the acquisition of shares related to taking the Company private and related expenses was appropriate from the standpoint of effective use of funds and enhancing corporate value.